SDC2 and neoplasm: Both saccharidic and non-saccharidic HS mimetics have shown to affect tumor cells and components of tumor microenvironment through different mechanisms, including the inhibition of cell surface-tethered HSPG signaling and HSPG-mediated cell adhesion, spreading, and angiogenesis [165,251].